How Epithalon May Influence Telomerase Activity
Early research in insects and rodents suggests that Epithalon may influence longevity-related pathways. In studies involving healthy fruit flies and rats, Epithalon was associated with reduced mortality rates. In mouse models predisposed to heart disease and cancer, Epithalon was also associated with increased lifespan compared with control groups. Researchers believe that part of this effect may be related to Epithalon’s ability to reduce free-radical activity, which can contribute to cellular damage over time. [1]
Epithalon’s potential anti-aging effects may also involve more than antioxidant activity alone. In vitro studies using human somatic cells suggest that Epithalon may activate telomerase, an enzyme involved in maintaining telomeres. Telomeres are protective structures located at the ends of chromosomes and play an important role in preserving DNA stability. [2]
By supporting telomerase activity, Epithalon may help protect telomeres and reduce the accumulation of DNA damage over time. Research suggests this may contribute to fewer errors within DNA strands, supporting the idea that Epithalon may help maintain genomic stability. [3] [4]
Because DNA damage and telomere shortening are closely associated with cellular aging, dysfunction, and certain disease processes, Epithalon remains an important area of interest in telomere, longevity, and cellular aging research.
How Epithalon May Influence DNA Activity
Epithalon’s effects on free radicals and telomeres may not fully explain its broader role in longevity research. Scientists continue to investigate how such a short peptide may influence complex biological processes, and one emerging area of interest is its potential effect on gene expression.
Cell culture research suggests that Epithalon may interact directly with DNA and influence the activity of specific genes. Studies indicate that Epithalon can interact with promoter regions of genes such as CD5, IL-2, MMP2, and Tram1. These genes are involved in important biological functions, including immune regulation, tissue remodeling, and cellular repair. [5]
CD5 and IL-2 are both associated with immune system activity, while MMP2 plays a key role in maintaining the extracellular matrix found in skin, tendons, and connective tissue. These findings suggest that Epithalon may support pathways related to immune function, tissue maintenance, and the body’s ability to respond to injury or everyday cellular stress.
Additional research in aging rats suggests that Epithalon may increase the expression of interferon gamma in aging lymphocytes. Interferon gamma is an important immune signaling molecule involved in antiviral defense and immune activation. It helps regulate macrophages, natural killer cells, and T cells, all of which play essential roles in protecting the body from infection and maintaining immune surveillance. [6]
Together, these findings suggest that Epithalon may influence longevity-related processes not only through telomerase and antioxidant pathways, but also through DNA regulation, immune signaling, and tissue-repair mechanisms.
The following are known DNA interactions of epithalon:
1
CD5 – Leads to immune cell differentiation
2
IL-2 – Increases IL-2 production, which regulates white blood cells
3
MMP2 – Enhances MMP activation and decreases inflammation
4
Tram1 – Enhances protein production
5
Arylalkylamine-N-acetyltransferase – Enhances melatonin production
6
pCREB t – Circadian rhythm regulation and anti-neoplastic effects
7
Telomerase – Telomerase activity increases cell longevity
How Epithalon May Support Skin Health and Cellular Aging
Epithalon May Influence Tumor Growth Research
Daily administration of Epithalon has been studied in rat models of cancer, where researchers observed a reduction in tumor growth compared with controls. In addition to slowing tumor development, Epithalon has also been investigated for its potential role in reducing metastasis, or the spread of cancer cells to distant tissues. [9] [10] [11]
Research has explored Epithalon in several cancer-related models, including HER2/neu-positive breast cancer, certain forms of leukemia, and testicular cancer. These studies suggest that Epithalon may influence pathways involved in abnormal cell growth, tumor progression, and cancer-related immune regulation. [12] [13]
While these findings are promising within research models, more studies are needed to better understand how Epithalon affects tumor biology, whether these effects translate across different cancer types, and what mechanisms may be involved.
How Epithalon May Influence Melatonin and Circadian Rhythm
Melatonin is a hormone produced by the pineal gland and is closely involved in sleep regulation, circadian rhythm, and aging-related biological processes. Research in rats suggests that Epithalon and related peptides may influence both the synthesis and release of melatonin by affecting proteins involved in melatonin production. [15]
Two important proteins studied in this pathway are arylalkylamine-N-acetyltransferase, also known as AANAT, and pCREB transcription protein. AANAT plays a key role in melatonin synthesis, while pCREB is involved in regulating gene activity connected to circadian signaling and melatonin release. [15]
Research in monkeys has also shown that Epithalon may help restore melatonin secretion toward normal patterns. Because melatonin production often changes with age, these findings make Epithalon an area of interest in circadian rhythm, sleep-wake cycle, pineal gland, and longevity-related research. [16]
Epithalon May Support Eyesight and Vision Research
Vladimir Khavinson is a Professor, President of the European region of the International Association of Gerontology and Geriatrics; Member of the Russian and Ukrainian Academies of Medical Sciences; Main gerontologist of the Health Committee of the Government of Saint Petersburg, Russia; Director of the Saint Petersburg Institute of Bioregulation and Gerontology; Vice-president of Gerontological Society of the Russian Academy of Sciences; Head of the Chair of Gerontology and Geriatrics of the North-Western State Medical University, St-Petersburg; Colonel of medical service (USSR, Russia), retired. Vladimir Khavinson is known for the discovery, experimental and clinical studies of new classes of peptide bioregulators as well as for the development of bioregulating peptide therapy. He is engaged in studying of the role of peptides in regulation of the mechanisms of ageing. His main field of actions is design, pre-clinical and clinical studies of new peptide geroprotectors. A 40-year-long investigation resulted in a multitude of methods of application of peptide bioregulators to slow down the process of ageing and increase human life span. Six peptide-based pharmaceuticals and 64 peptide food supplements have been introduced into clinical practice by V. Khavinson. He is an author of 196 patents (Russian and international) as well as of 775 scientific publications. His major achievements are presented in two books: “Peptides and Ageing” (NEL, 2002) and “Gerontological aspects of genome peptide regulation” (Karger AG, 2005). Vladimir Khavinson introduced scientific specialty “Gerontology and Geriatrics” in the Russian Federation on the governmental level. Academic Council headed by V. Khavinson has oversighted over 200 Ph.D. and Doctorate theses from many different countries.
